The Efficacy of Eltrombopag Treatment in Patients who developed Platelet Engraftment Failure after Allogeneic Stem Cell Transplantation: A Single Center Experience

Journal Title: Bezmiâlem Science - Year 2021, Vol 9, Issue 1

Abstract

Objective: Persistent thrombocytopenia is a common complication of allogeneic stem cell transplantation (ASCT). Treatment of platelet engraftment failure after ASCT remains controversial. Drugs, such as eltrombopag, are used for this purpose. Eltrombopag is an Food and Drug Administration -approved oral thrombopoietin receptor agonist. We aim to present the results of 12 patients treated with eltrombopag in our center for severe thrombocytopenia after ASCT. Methods: From January 2018 to February 2020, a total of 56 patients underwent ASCT. Twelve patients had persistent thrombocytopenia following ASCT. All patients received eltrombopag. Results: Primary platelet engraftment failure developed in six of 12 patients who developed persistent thrombocytopenia after ASCT. Secondary platelet engraftment failure developed in six of them. After eltrombopag treatment, eight (66.7%) patients achieved transfusion independence, whereas four patients (33.3%) could not. The maximum platelet count after the eltrombopag treatment was median 118.000 (range: 24,000-253,000)/μL. The median time from the start of eltrombopag until the platelet count was >50,000/ μL was 18 (range: 14-112) days. The median duration of treatment with eltrombopag was 70 (range: 26-180) days. Eltrombopag was discontinued in all patients who survived and had full platelet recovery. Conclusion: Thrombocytopenia after ASCT is a condition that should be treated as it can lead to life-threatening bleeding.

Authors and Affiliations

Ali ESER, Ayşen TİMURAĞAOĞLU

Keywords

Related Articles

Report of a Case of Signet Ring Carcinoma Presenting as Gastric Mucosal Thickening: A Diagnostic Dilemma

The number of cancer cases has been increasing worldwide. Early diagnosis and tumor resection remain as the most effective treatments for gastric cancer. However, early diagnosis is not always possible as it is frequentl...

Comparison of the Role of Endocan With Other Laboratory Tests in Diagnosis of Acute and Perforated Appendicitis in Children

Objective: In this study, we aimed to determine the role and efficacy of endocan and other routine laboratory tests to diagnose of acute appendicitis (AA) and determining perforation. Methods: One hundred patients under...

Acute Appendicitis Caused by Enterobius Vermicularis: Case Report

Enterobius vermicularis is one of the most common bowel parasites worldwide. It can be located in the lumen of the ceacum and appendix and rarely causes acute appendicitis disease. In this case, we present a 36 years old...

Effectiveness of Diffusion Tensor Imaging in the Microstructural Evaluation of Corpus Callosum and Brain Parenchyma in Children with Neurofibromatosis Type I

Objective: To compare tractional anisotropy (FA) and mean diffusivity (MD) values obtained from corpus callosum (CC), basal ganglion, thalamus, frontal and parietal white matter in NF1 patients compared to the control gr...

10.14235/bas.galenos.2020.4056

Objective: An important criterion that radiopaque poly-3-hydroxy butyrate (PHB) derivatives synthesized and characterized by our study group do not interact with DNA and bovine albumin to be developed as an intravenous c...

Download PDF file
  • EP ID EP691836
  • DOI 10.14235/bas.galenos.2020.5582
  • Views 131
  • Downloads 0

How To Cite

Ali ESER, Ayşen TİMURAĞAOĞLU (2021). The Efficacy of Eltrombopag Treatment in Patients who developed Platelet Engraftment Failure after Allogeneic Stem Cell Transplantation: A Single Center Experience. Bezmiâlem Science, 9(1), -. https://europub.co.uk./articles/-A-691836